Gut microbiome composition and risk factors in a large cross-sectional IBS cohort
Objective Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is difficult to diagnose and treat due to its inherent heterogeneity and unclear aetiology. Although there is evidence suggesting the importance of the microbiome in IBS, this association remains poorly defined. In t...
Saved in:
| Main Authors: | Melissa Agnello, Lauren N Carroll, Nabeel Imam, Rodolfo Pino, Christina Palmer, Ignacio Varas, Claire Greene, Maureen Hitschfeld, Sarah Gupta, Daniel E Almonacid, Michael C Hoaglin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000345.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovations in IBS Treatment: From Gut-Brain Therapies to Microbiome Modulation
by: Nicole Nitschke, et al.
Published: (2025-08-01) -
Role of Low FODMAP Diet and Probiotics on Gut Microbiome in Irritable Bowel Syndrome (IBS)
by: Shabnam Mohajir Selvaraj, et al.
Published: (2020-04-01) -
Gut bacteria interact directly with colonic mast cells in a humanized mouse model of IBS
by: Chiko Shimbori, et al.
Published: (2022-12-01) -
Mucoprotectants and gut barrier: mechanisms of action and clinical applications in IBS. Is there a possible role?
by: Francesco Rettura, et al.
Published: (2025-05-01) -
Healthy gut microbiomes are host-controllable microbiomes
by: Théodore Bouchez, et al.
Published: (2025-01-01)